Misplaced Pages

Vamicamide: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactivelyNext edit →Content deleted Content addedVisualWikitext
Revision as of 11:09, 17 December 2024 editMo18ekula (talk | contribs)248 edits ←Created page with '{{Infobox drug | drug_name = Vamicamide | image = Vamicamide.svg | width = 250px | caption = <!-- Clinical data --> | pronounce = | tradename = | Drugs.com = | MedlinePlus = | licence_CA = | licence_EU = | DailyMedID = | licence_US = | pregnancy_AU = | pregnancy_category = | dependency_liability = | addiction_liability = | routes_of_administration = | class = | ATC_prefix = | ATC_suffix = <!-- Legal status --> | legal_status = <!-- Phar...'  Revision as of 15:51, 18 December 2024 edit undoIdoghor Melody (talk | contribs)Autopatrolled, Event coordinators, Extended confirmed users, Page movers, IP block exemptions, New page reviewers, Pending changes reviewers32,961 editsm clean upTag: AWBNext edit →
Line 3: Line 3:
| image = Vamicamide.svg | image = Vamicamide.svg
| width = 250px | width = 250px
| caption = | caption =


<!-- Clinical data --> <!-- Clinical data -->
Line 21: Line 21:
| class = | class =
| ATC_prefix = | ATC_prefix =
| ATC_suffix = | ATC_suffix =


<!-- Legal status --> <!-- Legal status -->
| legal_status = | legal_status =


<!-- Pharmacokinetic data --> <!-- Pharmacokinetic data -->
Line 34: Line 34:
| elimination_half-life = | elimination_half-life =
| duration_of_action = | duration_of_action =
| excretion = | excretion =


<!-- Identifiers --> <!-- Identifiers -->
Line 58: Line 58:
| StdInChIKey = BWNLUIXQIHPUGO-RDTXWAMCSA-N | StdInChIKey = BWNLUIXQIHPUGO-RDTXWAMCSA-N
}} }}
Vamicamide is an antimuscarinic drug.<ref> Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K. General pharmacology of the new antimuscarinic compound vamicamide. Arzneimittelforschung. 1995 Dec;45(12):1274-84. PMID: 8595084. '''Vamicamide''' is an antimuscarinic drug.<ref>Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K. General pharmacology of the new antimuscarinic compound vamicamide. Arzneimittelforschung. 1995 Dec;45(12):1274-84. PMID 8595084.
</ref> </ref>


Vamicamide should be useful for the treatment of urinary frequency.<ref> Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M. Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol. 1995 Dec;154(6):2174-8. PMID: 7500484.</ref> Vamicamide should be useful for the treatment of urinary frequency.<ref>Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M. Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol. 1995 Dec;154(6):2174-8. PMID 7500484.</ref>


See also: ] (]). See also: ] (]).
Line 69: Line 69:


{{Acetylcholine receptor modulators}} {{Acetylcholine receptor modulators}}

] ]

Revision as of 15:51, 18 December 2024

Pharmaceutical compound
Vamicamide
Clinical data
Other namesUrocut
Identifiers
IUPAC name
  • (2R,4R)-4-(dimethylamino)-2-phenyl-2-pyridin-2-ylpentanamide
CAS Number
PubChem CID
ChemSpider
Chemical and physical data
FormulaC18H23N3O
Molar mass297.402 g·mol
3D model (JSmol)
SMILES
  • C(C(C1=CC=CC=C1)(C2=CC=CC=N2)C(=O)N)N(C)C
InChI
  • InChI=1S/C18H23N3O/c1-14(21(2)3)13-18(17(19)22,15-9-5-4-6-10-15)16-11-7-8-12-20-16/h4-12,14H,13H2,1-3H3,(H2,19,22)/t14-,18-/m1/s1
  • Key:BWNLUIXQIHPUGO-RDTXWAMCSA-N

Vamicamide is an antimuscarinic drug.

Vamicamide should be useful for the treatment of urinary frequency.

See also: Aminopentamide (Dimevamide).

References

  1. Yamamoto T, Honbo T, Tokoro K, Kojimoto Y, Kodama R, Ohtsuka M, Shimomura K. General pharmacology of the new antimuscarinic compound vamicamide. Arzneimittelforschung. 1995 Dec;45(12):1274-84. PMID 8595084.
  2. Yamamoto T, Koibuchi Y, Miura S, Sawada T, Ozaki R, Esumi K, Ohtsuka M. Effects of vamicamide on urinary bladder functions in conscious dog and rat models of urinary frequency. J Urol. 1995 Dec;154(6):2174-8. PMID 7500484.
Acetylcholine receptor modulators
Muscarinic acetylcholine receptor modulators
mAChRsTooltip Muscarinic acetylcholine receptors
Agonists
Antagonists
Precursors
(and prodrugs)
See also
Receptor/signaling modulators
Nicotinic acetylcholine receptor modulators
Acetylcholine metabolism/transport modulators
Nicotinic acetylcholine receptor modulators
nAChRsTooltip Nicotinic acetylcholine receptors
Agonists
(and PAMsTooltip positive allosteric modulators)
Antagonists
(and NAMsTooltip negative allosteric modulators)
Precursors
(and prodrugs)
See also
Receptor/signaling modulators
Muscarinic acetylcholine receptor modulators
Acetylcholine metabolism/transport modulators
Category: